Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer.
Caffo O, Fallani S, Marangon E, Nobili S, Cassetta MI, Murgia V, Sala F, Novelli A, Mini E, Zucchetti M, Galligioni E. Caffo O, et al. Among authors: galligioni e. Cancer Chemother Pharmacol. 2010 May;65(6):1197-202. doi: 10.1007/s00280-010-1255-7. Epub 2010 Feb 6. Cancer Chemother Pharmacol. 2010. PMID: 20140616 Clinical Trial.
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.
Grossi F, de Marinis F, Gebbia V, Riccardi F, Caffo O, Gamucci T, Ferraù F, Nardi M, Moscetti L, Boni L, Dondi D, Galligioni E. Grossi F, et al. Among authors: galligioni e. Cancer Chemother Pharmacol. 2012 Feb;69(2):369-75. doi: 10.1007/s00280-011-1710-0. Epub 2011 Jul 21. Cancer Chemother Pharmacol. 2012. PMID: 21833588 Clinical Trial.
Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.
Caffo O, Sava T, Comploj E, Fariello A, Zustovich F, Segati R, Sacco C, Valduga F, Cetto G, Galligioni E. Caffo O, et al. Among authors: galligioni e. BJU Int. 2008 Nov;102(9):1080-5. doi: 10.1111/j.1464-410X.2008.07779.x. Epub 2008 May 15. BJU Int. 2008. PMID: 18485028 Clinical Trial.
176 results